495 related articles for article (PubMed ID: 15601950)
1. Interaction between the corticotropin-releasing factor system and hypocretins (orexins): a novel circuit mediating stress response.
Winsky-Sommerer R; Yamanaka A; Diano S; Borok E; Roberts AJ; Sakurai T; Kilduff TS; Horvath TL; de Lecea L
J Neurosci; 2004 Dec; 24(50):11439-48. PubMed ID: 15601950
[TBL] [Abstract][Full Text] [Related]
2. Stress and arousal: the corticotrophin-releasing factor/hypocretin circuitry.
Winsky-Sommerer R; Boutrel B; de Lecea L
Mol Neurobiol; 2005 Dec; 32(3):285-94. PubMed ID: 16385142
[TBL] [Abstract][Full Text] [Related]
3. The corticotropin-releasing factor-hypocretin connection: implications in stress response and addiction.
Pañeda C; Winsky-Sommerer R; Boutrel B; de Lecea L
Drug News Perspect; 2005 May; 18(4):250-5. PubMed ID: 16034481
[TBL] [Abstract][Full Text] [Related]
4. Hypocretins regulate the anxiogenic-like effects of nicotine and induce reinstatement of nicotine-seeking behavior.
Plaza-Zabala A; Martín-García E; de Lecea L; Maldonado R; Berrendero F
J Neurosci; 2010 Feb; 30(6):2300-10. PubMed ID: 20147556
[TBL] [Abstract][Full Text] [Related]
5. Glucagon-like peptide 1 excites hypocretin/orexin neurons by direct and indirect mechanisms: implications for viscera-mediated arousal.
Acuna-Goycolea C; van den Pol A
J Neurosci; 2004 Sep; 24(37):8141-52. PubMed ID: 15371515
[TBL] [Abstract][Full Text] [Related]
6. Direct and indirect inhibition by catecholamines of hypocretin/orexin neurons.
Li Y; van den Pol AN
J Neurosci; 2005 Jan; 25(1):173-83. PubMed ID: 15634779
[TBL] [Abstract][Full Text] [Related]
7. Neuropeptide Y inhibits hypocretin/orexin neurons by multiple presynaptic and postsynaptic mechanisms: tonic depression of the hypothalamic arousal system.
Fu LY; Acuna-Goycolea C; van den Pol AN
J Neurosci; 2004 Oct; 24(40):8741-51. PubMed ID: 15470140
[TBL] [Abstract][Full Text] [Related]
8. Group III metabotropic glutamate receptors maintain tonic inhibition of excitatory synaptic input to hypocretin/orexin neurons.
Acuna-Goycolea C; Li Y; Van Den Pol AN
J Neurosci; 2004 Mar; 24(12):3013-22. PubMed ID: 15044540
[TBL] [Abstract][Full Text] [Related]
9. Role of innate and drug-induced dysregulation of brain stress and arousal systems in addiction: Focus on corticotropin-releasing factor, nociceptin/orphanin FQ, and orexin/hypocretin.
Martin-Fardon R; Zorrilla EP; Ciccocioppo R; Weiss F
Brain Res; 2010 Feb; 1314():145-61. PubMed ID: 20026088
[TBL] [Abstract][Full Text] [Related]
10. The brain hypocretins and their receptors: mediators of allostatic arousal.
Carter ME; Schaich Borg J; de Lecea L
Curr Opin Pharmacol; 2009 Feb; 9(1):39-45. PubMed ID: 19185540
[TBL] [Abstract][Full Text] [Related]
11. Orexinergic innervation of urocortin1 and cocaine and amphetamine regulated transcript neurons in the midbrain centrally projecting Edinger-Westphal nucleus.
Emmerzaal TL; vd Doelen RH; Roubos EW; Kozicz T
J Chem Neuroanat; 2013 Dec; 54():34-41. PubMed ID: 23958928
[TBL] [Abstract][Full Text] [Related]
12. Heterogeneous responses of nucleus incertus neurons to corticotrophin-releasing factor and coherent activity with hippocampal theta rhythm in the rat.
Ma S; Blasiak A; Olucha-Bordonau FE; Verberne AJ; Gundlach AL
J Physiol; 2013 Aug; 591(16):3981-4001. PubMed ID: 23671163
[TBL] [Abstract][Full Text] [Related]
13. The hypocretins and their role in narcolepsy.
Kroeger D; de Lecea L
CNS Neurol Disord Drug Targets; 2009 Aug; 8(4):271-80. PubMed ID: 19689309
[TBL] [Abstract][Full Text] [Related]
14. Synaptic interaction between hypocretin (orexin) and neuropeptide Y cells in the rodent and primate hypothalamus: a novel circuit implicated in metabolic and endocrine regulations.
Horvath TL; Diano S; van den Pol AN
J Neurosci; 1999 Feb; 19(3):1072-87. PubMed ID: 9920670
[TBL] [Abstract][Full Text] [Related]
15. Centrally administered orexin-A activates corticotropin-releasing factor-containing neurons in the hypothalamic paraventricular nucleus and central amygdaloid nucleus of rats: possible involvement of central orexins on stress-activated central CRF neurons.
Sakamoto F; Yamada S; Ueta Y
Regul Pept; 2004 May; 118(3):183-91. PubMed ID: 15003835
[TBL] [Abstract][Full Text] [Related]
16. Corticotropin-releasing factor depolarizes rat lateral vestibular nuclear neurons through activation of CRF receptors 1 and 2.
Wang Y; Chen ZP; Yang ZQ; Zhang XY; Li JM; Wang JJ; Zhu JN
Neuropeptides; 2019 Aug; 76():101934. PubMed ID: 31130301
[TBL] [Abstract][Full Text] [Related]
17. Hypocretinergic control of spinal cord motoneurons.
Yamuy J; Fung SJ; Xi M; Chase MH
J Neurosci; 2004 Jun; 24(23):5336-45. PubMed ID: 15190106
[TBL] [Abstract][Full Text] [Related]
18. Hypocretin (orexin) receptor subtypes differentially enhance acetylcholine release and activate g protein subtypes in rat pontine reticular formation.
Bernard R; Lydic R; Baghdoyan HA
J Pharmacol Exp Ther; 2006 Apr; 317(1):163-71. PubMed ID: 16352704
[TBL] [Abstract][Full Text] [Related]
19. Hypocretin/orexin and nociceptin/orphanin FQ coordinately regulate analgesia in a mouse model of stress-induced analgesia.
Xie X; Wisor JP; Hara J; Crowder TL; LeWinter R; Khroyan TV; Yamanaka A; Diano S; Horvath TL; Sakurai T; Toll L; Kilduff TS
J Clin Invest; 2008 Jul; 118(7):2471-81. PubMed ID: 18551194
[TBL] [Abstract][Full Text] [Related]
20. Fos immunoreactivity in hypocretin-synthesizing and hypocretin-1 receptor-expressing neurons: effects of diurnal and nocturnal spontaneous waking, stress and hypocretin-1 administration.
España RA; Valentino RJ; Berridge CW
Neuroscience; 2003; 121(1):201-17. PubMed ID: 12946712
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
